-
1
-
-
84896981541
-
Subviral particle as vaccine and vaccine platform
-
Tan M., Jiang X. Subviral particle as vaccine and vaccine platform. Curr Opin Virol 2014, 6C:24-33.
-
(2014)
Curr Opin Virol
, vol.6 C
, pp. 24-33
-
-
Tan, M.1
Jiang, X.2
-
2
-
-
0021238117
-
Human hepatitis B vaccine from recombinant yeast
-
McAleer W.J., Buynak E.B., Maigetter R.Z., Wampler D.E., Miller W.J., Hilleman M.R. Human hepatitis B vaccine from recombinant yeast. Nature 1984, 307:178-180.
-
(1984)
Nature
, vol.307
, pp. 178-180
-
-
McAleer, W.J.1
Buynak, E.B.2
Maigetter, R.Z.3
Wampler, D.E.4
Miller, W.J.5
Hilleman, M.R.6
-
3
-
-
0023217653
-
Summary of clinical findings on Engerix-B, a genetically engineered yeast derived hepatitis B vaccine
-
Andre F.E., Safary A. Summary of clinical findings on Engerix-B, a genetically engineered yeast derived hepatitis B vaccine. Postgrad Med J 1987, 63(Suppl.2):169-177.
-
(1987)
Postgrad Med J
, vol.63
, Issue.SUPPL.2
, pp. 169-177
-
-
Andre, F.E.1
Safary, A.2
-
4
-
-
0027050013
-
Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic
-
Kirnbauer R., Booy F., Cheng N., Lowy D.R., Schiller J.T. Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. Proc Natl Acad Sci U S A 1992, 89:12180-12184.
-
(1992)
Proc Natl Acad Sci U S A
, vol.89
, pp. 12180-12184
-
-
Kirnbauer, R.1
Booy, F.2
Cheng, N.3
Lowy, D.R.4
Schiller, J.T.5
-
5
-
-
77953028997
-
Vaccination with multimeric L2 fusion protein and L1 VLP or capsomeres to broaden protection against HPV infection
-
Jagu S., Kwak K., Garcea R.L., Roden R.B. Vaccination with multimeric L2 fusion protein and L1 VLP or capsomeres to broaden protection against HPV infection. Vaccine 2010, 28:4478-4486.
-
(2010)
Vaccine
, vol.28
, pp. 4478-4486
-
-
Jagu, S.1
Kwak, K.2
Garcea, R.L.3
Roden, R.B.4
-
6
-
-
8444249386
-
Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial
-
Harper D.M., Franco E.L., Wheeler C., Ferris D.G., Jenkins D., Schuind A., et al. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet 2004, 364:1757-1765.
-
(2004)
Lancet
, vol.364
, pp. 1757-1765
-
-
Harper, D.M.1
Franco, E.L.2
Wheeler, C.3
Ferris, D.G.4
Jenkins, D.5
Schuind, A.6
-
7
-
-
20944448032
-
Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial
-
Villa L.L., Costa R.L., Petta C.A., Andrade R.P., Ault K.A., Giuliano A.R., et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol 2005, 6:271-278.
-
(2005)
Lancet Oncol
, vol.6
, pp. 271-278
-
-
Villa, L.L.1
Costa, R.L.2
Petta, C.A.3
Andrade, R.P.4
Ault, K.A.5
Giuliano, A.R.6
-
8
-
-
84865328748
-
First HEV vaccine approved
-
Proffitt A. First HEV vaccine approved. Nat Biotechnol 2012, 30:300.
-
(2012)
Nat Biotechnol
, vol.30
, pp. 300
-
-
Proffitt, A.1
-
9
-
-
77956618583
-
Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial
-
Zhu F.C., Zhang J., Zhang X.F., Zhou C., Wang Z.Z., Huang S.J., et al. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet 2010, 376:895-902.
-
(2010)
Lancet
, vol.376
, pp. 895-902
-
-
Zhu, F.C.1
Zhang, J.2
Zhang, X.F.3
Zhou, C.4
Wang, Z.Z.5
Huang, S.J.6
-
10
-
-
84872034033
-
Characterization of porcine circovirus type 2 (PCV2) capsid particle assembly and its application to virus-like particle vaccine development
-
Wu P.C., Lin W.L., Wu C.M., Chi J.N., Chien M.S., Huang C. Characterization of porcine circovirus type 2 (PCV2) capsid particle assembly and its application to virus-like particle vaccine development. Appl Microbiol Biotechnol 2012, 95:1501-1507.
-
(2012)
Appl Microbiol Biotechnol
, vol.95
, pp. 1501-1507
-
-
Wu, P.C.1
Lin, W.L.2
Wu, C.M.3
Chi, J.N.4
Chien, M.S.5
Huang, C.6
-
11
-
-
44249105901
-
Porcine circovirus type 2 (PCV2) viral components immunomodulate recall antigen responses
-
Kekarainen T., Montoya M., Dominguez J., Mateu E., Segales J. Porcine circovirus type 2 (PCV2) viral components immunomodulate recall antigen responses. Vet Immunol Immunopathol 2008, 124:41-49.
-
(2008)
Vet Immunol Immunopathol
, vol.124
, pp. 41-49
-
-
Kekarainen, T.1
Montoya, M.2
Dominguez, J.3
Mateu, E.4
Segales, J.5
-
12
-
-
79551699386
-
Viral nanoparticles and virus-like particles: platforms for contemporary vaccine design
-
Plummer E.M., Manchester M. Viral nanoparticles and virus-like particles: platforms for contemporary vaccine design. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2011, 3:174-196.
-
(2011)
Wiley Interdiscip Rev Nanomed Nanobiotechnol
, vol.3
, pp. 174-196
-
-
Plummer, E.M.1
Manchester, M.2
-
13
-
-
84891629059
-
Adual vaccine candidate against norovirus and hepatitis E virus
-
Wang L., Cao D., Wei C., Meng X.J., Jiang X., Tan M. Adual vaccine candidate against norovirus and hepatitis E virus. Vaccine 2014, 32:445-452.
-
(2014)
Vaccine
, vol.32
, pp. 445-452
-
-
Wang, L.1
Cao, D.2
Wei, C.3
Meng, X.J.4
Jiang, X.5
Tan, M.6
-
14
-
-
84875592440
-
Polyvalent complexes for vaccine development
-
Wang L., Huang P., Fang H., Xia M., Zhong W., McNeal M.M., et al. Polyvalent complexes for vaccine development. Biomaterials 2013, 34:4480-4492.
-
(2013)
Biomaterials
, vol.34
, pp. 4480-4492
-
-
Wang, L.1
Huang, P.2
Fang, H.3
Xia, M.4
Zhong, W.5
McNeal, M.M.6
-
15
-
-
0344270909
-
X-ray structure of glutathione S-transferase from the malarial parasite Plasmodium falciparum
-
Fritz-Wolf K., Becker A., Rahlfs S., Harwaldt P., Schirmer R.H., Kabsch W., et al. X-ray structure of glutathione S-transferase from the malarial parasite Plasmodium falciparum. Proc Natl Acad Sci U S A 2003, 100:13821-13826.
-
(2003)
Proc Natl Acad Sci U S A
, vol.100
, pp. 13821-13826
-
-
Fritz-Wolf, K.1
Becker, A.2
Rahlfs, S.3
Harwaldt, P.4
Schirmer, R.H.5
Kabsch, W.6
-
16
-
-
70049087702
-
Dimerization of hepatitis E virus capsid protein E2s domain is essential for virus-host interaction
-
Li S., Tang X., Seetharaman J., Yang C., Gu Y., Zhang J., et al. Dimerization of hepatitis E virus capsid protein E2s domain is essential for virus-host interaction. PLoS Pathog 2009, 5:e1000537.
-
(2009)
PLoS Pathog
, vol.5
-
-
Li, S.1
Tang, X.2
Seetharaman, J.3
Yang, C.4
Gu, Y.5
Zhang, J.6
-
17
-
-
55249104282
-
Noroviral P particle: structure, function and applications in virus-host interaction
-
Tan M., Fang P., Chachiyo T., Xia M., Huang P., Fang Z., et al. Noroviral P particle: structure, function and applications in virus-host interaction. Virology 2008, 382:115-123.
-
(2008)
Virology
, vol.382
, pp. 115-123
-
-
Tan, M.1
Fang, P.2
Chachiyo, T.3
Xia, M.4
Huang, P.5
Fang, Z.6
-
18
-
-
27644437147
-
The p domain of norovirus capsid protein forms a subviral particle that binds to histo-blood group antigen receptors
-
Tan M., Jiang X. The p domain of norovirus capsid protein forms a subviral particle that binds to histo-blood group antigen receptors. JVirol 2005, 79:14017-14030.
-
(2005)
JVirol
, vol.79
, pp. 14017-14030
-
-
Tan, M.1
Jiang, X.2
-
19
-
-
80053580021
-
Acandidate dual vaccine against influenza and noroviruses
-
Xia M., Tan M., Wei C., Zhong W., Wang L., McNeal M., et al. Acandidate dual vaccine against influenza and noroviruses. Vaccine 2011, 29:7670-7677.
-
(2011)
Vaccine
, vol.29
, pp. 7670-7677
-
-
Xia, M.1
Tan, M.2
Wei, C.3
Zhong, W.4
Wang, L.5
McNeal, M.6
-
20
-
-
78650633210
-
Norovirus P particle, a novel platform for vaccine development and antibody production
-
Tan M., Huang P., Xia M., Fang P.A., Zhong W., McNeal M., et al. Norovirus P particle, a novel platform for vaccine development and antibody production. JVirol 2011, 85:753-764.
-
(2011)
JVirol
, vol.85
, pp. 753-764
-
-
Tan, M.1
Huang, P.2
Xia, M.3
Fang, P.A.4
Zhong, W.5
McNeal, M.6
-
21
-
-
80052838426
-
Molecular virology of hepatitis E virus
-
Ahmad I., Holla R.P., Jameel S. Molecular virology of hepatitis E virus. Virus Res 2011, 161:47-58.
-
(2011)
Virus Res
, vol.161
, pp. 47-58
-
-
Ahmad, I.1
Holla, R.P.2
Jameel, S.3
-
22
-
-
80053400176
-
Norovirus P particle as a platform for antigen presentation
-
Tan M., Xia M., Huang P., Wang L., Zhong W., McNeal M., et al. Norovirus P particle as a platform for antigen presentation. Procedia Vaccinol 2011, 4:19-26.
-
(2011)
Procedia Vaccinol
, vol.4
, pp. 19-26
-
-
Tan, M.1
Xia, M.2
Huang, P.3
Wang, L.4
Zhong, W.5
McNeal, M.6
-
23
-
-
33746190727
-
C-terminal arginine cluster is essential for receptor binding of norovirus capsid protein
-
Tan M., Meller J., Jiang X. C-terminal arginine cluster is essential for receptor binding of norovirus capsid protein. JVirol 2006, 80:7322-7331.
-
(2006)
JVirol
, vol.80
, pp. 7322-7331
-
-
Tan, M.1
Meller, J.2
Jiang, X.3
-
24
-
-
2642552973
-
The P domain of norovirus capsid protein forms dimer and binds to histo-blood group antigen receptors
-
Tan M., Hegde R.S., Jiang X. The P domain of norovirus capsid protein forms dimer and binds to histo-blood group antigen receptors. JVirol 2004, 78:6233-6242.
-
(2004)
JVirol
, vol.78
, pp. 6233-6242
-
-
Tan, M.1
Hegde, R.S.2
Jiang, X.3
-
25
-
-
7044220403
-
E.coli-expressed recombinant norovirus capsid proteins maintain authentic antigenicity and receptor binding capability
-
Tan M., Zhong W., Song D., Thornton S., Jiang X. E.coli-expressed recombinant norovirus capsid proteins maintain authentic antigenicity and receptor binding capability. JMed Virol 2004, 74:641-649.
-
(2004)
JMed Virol
, vol.74
, pp. 641-649
-
-
Tan, M.1
Zhong, W.2
Song, D.3
Thornton, S.4
Jiang, X.5
-
26
-
-
78751706360
-
Terminal modifications of norovirus P domain resulted in a new type of subviral particles, the small P particles
-
Tan M., Fang P.A., Xia M., Chachiyo T., Jiang W., Jiang X. Terminal modifications of norovirus P domain resulted in a new type of subviral particles, the small P particles. Virology 2011, 410:345-352.
-
(2011)
Virology
, vol.410
, pp. 345-352
-
-
Tan, M.1
Fang, P.A.2
Xia, M.3
Chachiyo, T.4
Jiang, W.5
Jiang, X.6
-
27
-
-
0037560150
-
Noroviruses bind to human ABO, lewis, and secretor histo-blood group antigens: identification of 4 distinct strain-specific patterns
-
Huang P., Farkas T., Marionneau S., Zhong W., Ruvoen-Clouet N., Morrow A.L., et al. Noroviruses bind to human ABO, lewis, and secretor histo-blood group antigens: identification of 4 distinct strain-specific patterns. JInfect Dis 2003, 188:19-31.
-
(2003)
JInfect Dis
, vol.188
, pp. 19-31
-
-
Huang, P.1
Farkas, T.2
Marionneau, S.3
Zhong, W.4
Ruvoen-Clouet, N.5
Morrow, A.L.6
-
28
-
-
18744372741
-
Norovirus and histo-blood group antigens: demonstration of a wide spectrum of strain specificities and classification of two major binding groups among multiple binding patterns
-
Huang P., Farkas T., Zhong W., Tan M., Thornton S., Morrow A.L., et al. Norovirus and histo-blood group antigens: demonstration of a wide spectrum of strain specificities and classification of two major binding groups among multiple binding patterns. JVirol 2005, 79:6714-6722.
-
(2005)
JVirol
, vol.79
, pp. 6714-6722
-
-
Huang, P.1
Farkas, T.2
Zhong, W.3
Tan, M.4
Thornton, S.5
Morrow, A.L.6
-
29
-
-
83155182848
-
Norovirus vaccine against experimental human Norwalk virus illness
-
Atmar R.L., Bernstein D.I., Harro C.D., Al-Ibrahim M.S., Chen W.H., Ferreira J., et al. Norovirus vaccine against experimental human Norwalk virus illness. NEngl J Med 2011, 365:2178-2187.
-
(2011)
NEngl J Med
, vol.365
, pp. 2178-2187
-
-
Atmar, R.L.1
Bernstein, D.I.2
Harro, C.D.3
Al-Ibrahim, M.S.4
Chen, W.H.5
Ferreira, J.6
-
30
-
-
84867530148
-
Predicting susceptibility to norovirus GII.4 by use of a challenge model involving humans
-
Frenck R., Bernstein D.I., Xia M., Huang P., Zhong W., Parker S., et al. Predicting susceptibility to norovirus GII.4 by use of a challenge model involving humans. JInfect Dis 2012, 206:1386-1393.
-
(2012)
JInfect Dis
, vol.206
, pp. 1386-1393
-
-
Frenck, R.1
Bernstein, D.I.2
Xia, M.3
Huang, P.4
Zhong, W.5
Parker, S.6
-
31
-
-
77957005956
-
Serological correlate of protection against norovirus-induced gastroenteritis
-
Reeck A., Kavanagh O., Estes M.K., Opekun A.R., Gilger M.A., Graham D.Y., et al. Serological correlate of protection against norovirus-induced gastroenteritis. JInfect Dis 2010, 202:1212-1218.
-
(2010)
JInfect Dis
, vol.202
, pp. 1212-1218
-
-
Reeck, A.1
Kavanagh, O.2
Estes, M.K.3
Opekun, A.R.4
Gilger, M.A.5
Graham, D.Y.6
-
32
-
-
33644593097
-
Putative neutralization epitopes and broad cross-genotype neutralization of hepatitis E virus confirmed by a quantitative cell-culture assay
-
Emerson S.U., Clemente-Casares P., Moiduddin N., Arankalle V.A., Torian U., Purcell R.H. Putative neutralization epitopes and broad cross-genotype neutralization of hepatitis E virus confirmed by a quantitative cell-culture assay. JGen Virol 2006, 87:697-704.
-
(2006)
JGen Virol
, vol.87
, pp. 697-704
-
-
Emerson, S.U.1
Clemente-Casares, P.2
Moiduddin, N.3
Arankalle, V.A.4
Torian, U.5
Purcell, R.H.6
-
33
-
-
84887167395
-
Serological evidence for a hepatitis e virus-related agent in goats in the United States
-
Sanford B.J., Emerson S.U., Purcell R.H., Engle R.E., Dryman B.A., Cecere T.E., et al. Serological evidence for a hepatitis e virus-related agent in goats in the United States. Transbound Emerg Dis 2013, 60:538-545.
-
(2013)
Transbound Emerg Dis
, vol.60
, pp. 538-545
-
-
Sanford, B.J.1
Emerson, S.U.2
Purcell, R.H.3
Engle, R.E.4
Dryman, B.A.5
Cecere, T.E.6
-
34
-
-
0035896012
-
Papillomavirus capsid protein expression in Escherichia coli: purification and assembly of HPV11 and HPV16 L1
-
Chen X.S., Casini G., Harrison S.C., Garcea R.L. Papillomavirus capsid protein expression in Escherichia coli: purification and assembly of HPV11 and HPV16 L1. JMol Biol 2001, 307:173-182.
-
(2001)
JMol Biol
, vol.307
, pp. 173-182
-
-
Chen, X.S.1
Casini, G.2
Harrison, S.C.3
Garcea, R.L.4
-
35
-
-
79961228943
-
Crystal structure of the human astrovirus capsid spike
-
Dong J., Dong L., Mendez E., Tao Y. Crystal structure of the human astrovirus capsid spike. Proc Natl Acad Sci U S A 2011, 108:12681-12686.
-
(2011)
Proc Natl Acad Sci U S A
, vol.108
, pp. 12681-12686
-
-
Dong, J.1
Dong, L.2
Mendez, E.3
Tao, Y.4
-
36
-
-
43949129092
-
Structural basis for the receptor binding specificity of Norwalk virus
-
Bu W., Mamedova A., Tan M., Xia M., Jiang X., Hegde R.S. Structural basis for the receptor binding specificity of Norwalk virus. JVirol 2008, 82:5340-5347.
-
(2008)
JVirol
, vol.82
, pp. 5340-5347
-
-
Bu, W.1
Mamedova, A.2
Tan, M.3
Xia, M.4
Jiang, X.5
Hegde, R.S.6
-
37
-
-
34249822248
-
Structural basis for the recognition of blood group trisaccharides by norovirus
-
Cao S., Lou Z., Tan M., Chen Y., Liu Y., Zhang Z., et al. Structural basis for the recognition of blood group trisaccharides by norovirus. JVirol 2007, 81:5949-5957.
-
(2007)
JVirol
, vol.81
, pp. 5949-5957
-
-
Cao, S.1
Lou, Z.2
Tan, M.3
Chen, Y.4
Liu, Y.5
Zhang, Z.6
-
38
-
-
79960933686
-
Crystallography of a lewis-binding norovirus, elucidation of strain-specificity to the polymorphic human histo-blood group antigens
-
Chen Y., Tan M., Xia M., Hao N., Zhang X.C., Huang P., et al. Crystallography of a lewis-binding norovirus, elucidation of strain-specificity to the polymorphic human histo-blood group antigens. PLoS Pathog 2011, 7:e1002152.
-
(2011)
PLoS Pathog
, vol.7
-
-
Chen, Y.1
Tan, M.2
Xia, M.3
Hao, N.4
Zhang, X.C.5
Huang, P.6
-
39
-
-
48249142845
-
Atomic resolution structural characterization of recognition of histo-blood group antigens by Norwalk virus
-
Choi J.M., Hutson A.M., Estes M.K., Prasad B.V. Atomic resolution structural characterization of recognition of histo-blood group antigens by Norwalk virus. Proc Natl Acad Sci U S A 2008, 105:9175-9180.
-
(2008)
Proc Natl Acad Sci U S A
, vol.105
, pp. 9175-9180
-
-
Choi, J.M.1
Hutson, A.M.2
Estes, M.K.3
Prasad, B.V.4
-
40
-
-
84857030465
-
Structure, stability and dynamics of norovirus P domain derived protein complexes studied by native mass spectrometry
-
Bereszczak J.Z., Barbu I.M., Tan M., Xia M., Jiang X., van Duijn E., et al. Structure, stability and dynamics of norovirus P domain derived protein complexes studied by native mass spectrometry. JStruct Biol 2012, 177:273-282.
-
(2012)
JStruct Biol
, vol.177
, pp. 273-282
-
-
Bereszczak, J.Z.1
Barbu, I.M.2
Tan, M.3
Xia, M.4
Jiang, X.5
van Duijn, E.6
|